Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
GomSpace Group | GOMX | Nov 25, 2024 | 4.50 | +0.22 |
Goobit Group | BTCX | Nov 25, 2024 | 0.15 | +4.90 |
Goodbye Kansas Group | GBK | Nov 25, 2024 | 1.34 | -3.60 |
Gosol Energy Group AB | GOSOL | Nov 25, 2024 | 1.06 | -7.99 |
Greater Than | GREAT | Nov 25, 2024 | 28.00 | -3.11 |
Green Landscaping Group | GREEN | Nov 25, 2024 | 71.00 | +1.57 |
Greenmerc | GMERCB | Nov 25, 2024 | 6.32 | -3.66 |
Gruvaktiebolaget Viscaria | VISC | Nov 25, 2024 | 22.50 | +1.81 |
Gränges | GRNG | Nov 25, 2024 | 121.20 | +2.89 |
Grängesberg Exploration Holding | GRANGX | Nov 25, 2024 | 9.21 | +2.33 |
Guard Therapeutics International | GUARD | Nov 25, 2024 | 21.00 | +1.94 |
Guideline Geo | GGEO | Nov 25, 2024 | 7.92 | -0.25 |
Gullberg & Jansson | GJAB | Nov 25, 2024 | 16.50 | +7.49 |
H&D Wireless Sweden Holding B | HDWB | Nov 25, 2024 | 0.00 | +3.70 |
H&M B | HMB | Nov 25, 2024 | 154.15 | -0.80 |
HAKI Safety A | HAKIA | Nov 25, 2024 | 26.00 | -3.70 |
HAKI Safety B | HAKIB | Nov 25, 2024 | 25.70 | +1.18 |
Hamlet BioPharma AB (publ) | HAMLETB | Nov 25, 2024 | 2.76 | +5.34 |
Hansa Biopharma | HNSA | Nov 25, 2024 | 31.50 | +2.67 |
Hanza AB | HANZA | Nov 25, 2024 | 65.85 | -3.23 |
Harm Reduction Group | NOHARM | Nov 25, 2024 | 0.04 | -15.33 |
Havsfrun Investment | HAVS | Nov 25, 2024 | 14.40 | +5.11 |
Havsfrun Investment B | HAVB | Nov 25, 2024 | 14.40 | +5.11 |
Haypp Group | HAYPP | Nov 25, 2024 | 62.20 | +1.63 |
Headsent | VIMAB | Nov 25, 2024 | 7.50 | 0.00 |
Heba B | HEBAB | Nov 25, 2024 | 31.50 | +0.64 |
Hedera Group | HEGR | Nov 25, 2024 | 2.42 | 0.00 |
Heimstaden Pref | HEIMPREF | Nov 25, 2024 | 14.66 | +4.42 |
Heliospectra | HELIO | Nov 25, 2024 | 0.46 | -5.74 |
Hemnet Group | HEM | Nov 25, 2024 | 330.20 | +1.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.